Maxim Upgrades Gilead Sciences to Buy What This Could Mean for Investors ECBBanks Rift Stalls Europes Push to Reduce Reliance on US Payment Giants Visa and Mastercard Lenovo Reports Strong Q4 Revenue Growth on Robust PC Demand Shares Jump 15 Q4 Earnings Season Updates EID Parry Reports Loss Marksans Pharma and Astra Microwave See Profit Gains NASA Selects Blue Origin for Key Moon Base Mission Edging Out SpaceX New York Fed Study Reveals LowerIncome Households Bear Brunt of Rising Gas Prices CTOR Q1 2026 Earnings EPS Falls Far Below Estimates as PreRevenue Company Continues RD Investment Kayne Anderson BDC Inc KBDC Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response WEC Q1 2026 Earnings EPS Surpasses Expectations Stock Rises FormFactor Inc Q1 2026 Earnings EPS Surges Past Estimates Sending Shares Higher INSP Q1 2026 Earnings EPS Misses Estimates by 376 Stock Edges Higher WEN Q1 2026 Earnings EPS Surpasses Estimates by 241 as Value Initiatives Drive Profitability Champion Homes SKY Rallies 208 as Builders Sector Momentum Builds Forafric Global PLC Warrants AFRIW Holds Steady at 075 Amid Tight Trading Range Cathay General Bancorp CATY Holds Steady Near Support Eyes Resistance Ahead OFS Credit Company OCCI Slides 21 as Pressure Mounts on Key Support Elite Express Holding ETS Rises 343 Testing Key Resistance at 060 Investment Manager Trims Stock Position Following 80 Surge Since April SIM Q1 2023 Earnings EPS Falls Short of Estimates Missing by Over 57 Bunge Limited BG Holds Steady Near 121 Signs of Consolidation Amid Sector Pressure Prestige Consumer Healthcare Inc PBH Edges Higher Amid Defensive Appeal Bold Eagle Acquisition Corp BEAG Holds Steady Near Support A Quiet Moment for a Special Purpose Acquisition Vehicle ARKO Petroleum Corp APC Stock Slips Nearly 2 as Shares Approach Key Support Renatus Tactical Acquisition Corp I RTAC Holds Steady Near Resistance Key Levels in Focus RCI Hospitality RICK Gains 174 Approaching Key Resistance at 2576 Brandywine Realty Trust BDN Edges Higher as Real Estate Sector Finds Footing Xenetic Biosciences XBIO Modestly Advances as Biotech Stock Tests Key Resistance Zone